-
La corte está evaluando la posibilidad de revertir las normas de la FDA que han facilitado los abortos con medicamentos. Los proveedores dicen que esos cambios han tenido un gran impacto en New Hampshire.
-
The state's new reproductive shield law is at the heart of the lawsuit.
-
Democrats in the Maine House passed a contentious proposal expanding abortion access to later in a pregnancy. The move increases the likelihood that Maine will have some of the least restrictive abortion laws in the country. Steve Mistler has more.
-
With summer in full swing, so are the golf clubs. In Middlebury, a new mini golf course is putting a unique twist on the old favorite. Vermont Public’s Jenn Jarecki went to check it out.
-
One year since the overturning of Roe v. Wade, ending the federal right to an abortion, Connecticut health care leaders and lawmakers look to protect residents' rights.
-
As state legislatures across the United States enact new prohibitions against abortion and gender-affirming medical care, Republican Gov. Phil Scott Wednesday signed two bills that will protect health care providers and their patients from criminal charges filed by prosecutors outside the state of Vermont.
-
The appeals court ordered that the drug only be allowed for use through seven weeks of pregnancy instead of 10. It also prohibits it from being sent through the mail, an option that abortion providers say is important for ensuring access in rural states such as Maine.
-
A decision from a Texas court last week that revokes FDA approval of mifepristone is on hold till Friday to allow the federal government time to appeal.
-
Advocates said the March for Life rally is designed to send a message to Connecticut state lawmakers during the legislative session. Abortion remains legal in Connecticut; the right to an abortion was codified in state law in 1990.
-
A federal anti-abortion case being heard by a Texas judge has the potential to impact states where abortion is legal. A federal judge in Texas appointed by Donald Trump is expected to rule soon whether to take an abortion pill, long ago approved by the FDA, off the market.